COMMITED TO YOU

Research
& Grants

OUR MISSION

Dedicated
to embryonic
competence and
research

Since 2014, the Foundation for Embryonic Competence (FEC) has awarded millions to support research in the field of embryonic competence. We are proud to support numerous research studies through our supported research and fellowship grant programs.

YOU CAN APPLY ANYTIME

Research & Grants

How to Apply

The grant application process is now open. Grant applications are due by May 15, 2016, and awards will be announced by June 30, 2016. The funds will be available for beginning research by mid-July.

Publications

With proceeds earned from PGTseq-A and PGTseq-M, FEC funds research in embryonic reproductive potential. See the sampling of publications generated from this research.

All funding is made possible through proceeds earned through our PGTseq-A and PGTseq-M diagnostic tests.

OUR FUNDS

How we
make funds

Research into factors relating to embryonic reproductive potential has been difficult to fund. Traditional sources, such as the National Institutes of Health (NIH), are prohibited from supporting much of the work needed in this critical area.

Investigator-initiated grants from the pharmaceutical industry and biotechnology companies have also diminished in recent years. The lack of support likely means that some investigators with great ideas, particularly those who are young and without established funding histories, will be unable to pursue meaningful research, thus having the undesired effect of slowing progress in our field.

OUR PROGRAM

Fellowship
grant program

The FEC recently established a grant program to provide up to $70,000 to support individual first- and second-year reproductive endocrinology fellows investigating factors influencing embryonic reproductive competence. This includes investigating related techniques and factors that may actually improve the opportunity for embryos to implant and progress to delivery.

OUR RESEARCH

Supported research

Solaire

Solaire is a clinical trial that aims to assess the impact of NexCCS on patients with low ovarian reserve in order to improve in vitro fertilization (IVF) success and decrease the time to successful pregnancy.

The Natural Cycle Study

The Natural Cycle Study monitors the development of naturally selected follicles without the use of stimulating drugs. The goal is to examine endometrial changes and assess aneuploidy rates in embryos within the natural IVF cycle.

Summit

Summit aims to determine the impact of two FDA-approved blastocyst culture media on pregnancy outcomes.

Nexgen

Nexgen is a clinical trial that aims to assess the effectiveness of next generation sequencing (NGS) based preimplantation genetic diagnosis (PGD) to aid in the selection of embryos for transfer during clinical IVF cycles.

EnMotion

The objective of the EnMotion clinical research study is to evaluate the impact of a dynamic culture system, or a culture system where embryos can move as they do naturally, on the reproductive potential of embryos created during IVF.

Sperm Chromatin Structure Assay (SCSA)

The purpose of this study is to determine if sperm DNA fragmentation is associated with IVF outcomes when euploid embryos are transferred.

Message icon